Article

A New Hope for Liquid Biopsies: Early Detection of Pancreatic Cancer By Means of Protease Activity Detection in Serum Applying a Hierarchical Decision Structure

2022-10-21

Abstract excerpt

<h4>ABSTRACT</h4> Over the last 6 years, five-year survival rate for pancreatic cancer patients has increased from 6 to 10% after the initial diagnosis, which makes it one of the deadliest cancer types. This disease is known as the “silent killer” because early detection is challenging due to the location of the pancreas in the body and the nonspecific clinical symptoms. The Bossmann group has developed ultrasensi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d5596cc4-e555-5cef-9260-8b1e655e1250
DOI: 10.1101/2022.10.18.22281240

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A New Hope for Liquid Biopsies: Early Detection of Pancreatic Cancer By Means of Protease Activity Detection in Serum Applying a Hierarchical Decision StructureDOI 10.1101/2022.10.18.22281240Read

Nano Sensing for Early Diagnosis of Pancreatic CancerSemantic proximity Read

Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic CancerSemantic proximity Read

Early Diagnosis of Pancreatic Ductal Adenocarcinoma by Signal-Enhanced Lateral Flow Immunoassay: SELFISemantic proximity Read

Early detection of pancreatic cancer.Semantic proximity Read

Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancerSemantic proximity Read

The Potential Implementation of Biosensors for the Diagnosis of Biomarkers of Various CancerSemantic proximity Read

Novel Methylation Biomarker Panel for the Early Detection of Pancreatic CancerSemantic proximity Read

Noninvasive lung cancer detection via pulmonary protease profilingSemantic proximity Read

Artificial intelligence in pancreatic cancer histopathology and diagnostics - implications for clinical decisions and biomarker discovery?Semantic proximity Read

Immunosignaturing Microarrays Distinguish Antibody Profiles of Related Pancreatic DiseasesSemantic proximity Read

Chronic Inflammation Induced by Escherichia coli Blood Infections as a Risk Factor for Pancreatic Cancer ProgressionSemantic proximity Read

Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detectionSemantic proximity Read